MENU
PVLA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Palvella Therapeutics (PVLA) Ownership - Who owns Palvella Therapeutics?

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies... Show more

Profile

Industry
N/A
Address
353 W. Lancaster Avenue
Phone
+1 484 253-1461
Employees
29
Web
https://www.palvellatx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.99B
P/E Ratio
14.22
Total Cash
250.58M
Projected Growth
N/A
Total Debt
535K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
17.39
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
PVLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
353 W. Lancaster Avenue
Phone
+1 484 253-1461
Employees
29
Web
https://www.palvellatx.com
Who owns Palvella Therapeutics? PVLA symbol Ownership - Tickeron.com